TRI Stock Overview
TrivarX Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
TrivarX Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.032 |
| 52 Week High | AU$0.042 |
| 52 Week Low | AU$0.02 |
| Beta | 0.81 |
| 1 Month Change | 14.29% |
| 3 Month Change | 30.61% |
| 1 Year Change | 60.00% |
| 3 Year Change | -80.00% |
| 5 Year Change | -88.57% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| TRI | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 23.1% | 3.0% | -1.3% |
| 1Y | 60.0% | 66.7% | 6.0% |
Return vs Industry: TRI underperformed the Australian Healthcare Services industry which returned 66.7% over the past year.
Return vs Market: TRI exceeded the Australian Market which returned 6% over the past year.
Price Volatility
| TRI volatility | |
|---|---|
| TRI Average Weekly Movement | 20.3% |
| Healthcare Services Industry Average Movement | 7.9% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.7% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: TRI's share price has been volatile over the past 3 months.
Volatility Over Time: TRI's weekly volatility has decreased from 47% to 20% over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | n/a | trivarx.com |
TrivarX Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023.
TrivarX Limited Fundamentals Summary
| TRI fundamental statistics | |
|---|---|
| Market cap | AU$10.83m |
| Earnings (TTM) | -AU$3.74m |
| Revenue (TTM) | AU$19.42k |
557.6x
P/S Ratio-2.9x
P/E RatioIs TRI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRI income statement (TTM) | |
|---|---|
| Revenue | AU$19.42k |
| Cost of Revenue | -AU$1.00 |
| Gross Profit | AU$19.43k |
| Other Expenses | AU$3.75m |
| Earnings | -AU$3.74m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 100.01% |
| Net Profit Margin | -19,230.59% |
| Debt/Equity Ratio | 0% |
How did TRI perform over the long term?
See historical performance and comparison